|
AU3570495A
(en)
|
1994-09-22 |
1996-04-09 |
Quadrant Holdings Cambridge Limited |
Compositions for use in rehydration and nutrition during athletic exercise and methods of making same
|
|
US6946117B1
(en)
*
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
EP1071465A1
(en)
*
|
1998-03-18 |
2001-01-31 |
Ronai, Peter |
Amorphous glasses for stabilising sensitive products
|
|
US6190701B1
(en)
|
1999-03-17 |
2001-02-20 |
Peter M. Ronai |
Composition and method for stable injectable liquids
|
|
US6102896A
(en)
*
|
1999-09-08 |
2000-08-15 |
Cambridge Biostability Limited |
Disposable injector device
|
|
DE19943491B4
(de)
*
|
1999-09-10 |
2010-04-01 |
Südzucker AG Mannheim/Ochsenfurt |
Verbesserte Komprimate
|
|
WO2001037804A2
(en)
*
|
1999-11-22 |
2001-05-31 |
Universal Preservation Technologies, Inc. |
Preservation and formulation of bioactive materials
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
US6653062B1
(en)
|
2000-07-26 |
2003-11-25 |
Wisconsin Alumni Research Foundation |
Preservation and storage medium for biological materials
|
|
GB0024271D0
(en)
*
|
2000-09-25 |
2000-11-15 |
Colaco Camilo |
Improved methods and compositions for pulmonary delivery of actives
|
|
AU2001211986B2
(en)
*
|
2000-10-13 |
2007-04-26 |
Cambridge Biostability Ltd. |
Composition and method for stable injectable liquids
|
|
EP1452171B1
(en)
*
|
2000-10-13 |
2009-12-02 |
Cambridge Biostability Limited |
Pharmaceutical liquid suspensions
|
|
RU2259817C2
(ru)
*
|
2000-10-13 |
2005-09-10 |
Кембридж Байостэбилити Лтд. |
Композиция для доставки стабильных инъецируемых жидкостей и способ доставки
|
|
WO2002032398A2
(en)
*
|
2000-10-16 |
2002-04-25 |
Massachusetts Institute Of Technology |
Lipid-protein-sugar particles for drug delivery
|
|
US7153472B1
(en)
|
2000-11-22 |
2006-12-26 |
Quadrant Drug Delivery Limited |
Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
|
|
US6623762B2
(en)
|
2001-02-16 |
2003-09-23 |
Cambridge Biostability Ltd. |
Composition and method for controlled release injections
|
|
FR2825276B1
(fr)
*
|
2001-05-31 |
2004-11-26 |
Seppic Sa |
Adujvant d'immunite sous forme solide et vaccin le contenant
|
|
JP4169344B2
(ja)
*
|
2001-07-02 |
2008-10-22 |
旭化成ファーマ株式会社 |
アルカリホスファターゼ安定化方法
|
|
TWI332009B
(https=)
*
|
2001-08-10 |
2010-10-21 |
Hayashibara Biochem Lab |
|
|
GB2379390B
(en)
|
2001-09-11 |
2005-01-26 |
Caretek Medical Ltd |
A novel drug delivery technology
|
|
JP2005514393A
(ja)
|
2001-12-19 |
2005-05-19 |
ネクター セラピューティクス |
アミノグリコシドの肺への供給
|
|
US7943179B2
(en)
|
2003-09-23 |
2011-05-17 |
Massachusetts Institute Of Technology |
pH triggerable polymeric particles
|
|
ATE411797T2
(de)
*
|
2003-10-23 |
2008-11-15 |
Otsuka Pharma Co Ltd |
Sterile injizierbare aripiprazol-formulierung mit kontrollierter freisetzung und verfahren
|
|
FR2873386B1
(fr)
|
2004-07-22 |
2011-01-14 |
Agence Francaise De Securite Sanitaire Des Aliments Afssa |
Composition vaccinale contre le rhodococcus equi
|
|
US20060045891A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Lovalenti Phillip M |
Density-matched suspension vehicles and pharmaceutical suspensions
|
|
US20060142630A1
(en)
*
|
2004-12-29 |
2006-06-29 |
Attila Meretei |
Systems and methods for treating a thrombus in a blood vessel
|
|
US7515971B1
(en)
*
|
2005-09-09 |
2009-04-07 |
Pacesetter, Inc. |
Left atrial pressure sensor lead
|
|
GB2430880A
(en)
*
|
2005-10-04 |
2007-04-11 |
Cambridge Biostability Ltd |
Pharmaceutical compositions stabilized in glassy particles
|
|
GB0523638D0
(en)
*
|
2005-11-21 |
2005-12-28 |
Cambridge Biostability Ltd |
Pharmaceutical device for the administration of substances to patients
|
|
US8946200B2
(en)
|
2006-11-02 |
2015-02-03 |
Southwest Research Institute |
Pharmaceutically active nanosuspensions
|
|
DE102006056790B3
(de)
*
|
2006-12-01 |
2008-01-17 |
IfP Privates Institut für Produktqualität GmbH |
Laboreinmalartikel für Analyse und Diagnosik
|
|
ATE515554T1
(de)
*
|
2006-12-04 |
2011-07-15 |
Merck Patent Gmbh |
Furochromanderivate
|
|
WO2008092084A2
(en)
|
2007-01-26 |
2008-07-31 |
Centocor, Inc. |
Injectable non-aqueous suspension with high concentration of therapeutic agent
|
|
MY152789A
(en)
*
|
2007-07-31 |
2014-11-28 |
Otsuka Pharma Co Ltd |
Methods for producing aripiprazole suspension and freeze-dried formulation
|
|
JP2011514337A
(ja)
*
|
2008-02-25 |
2011-05-06 |
ノババックス，インコーポレイテッド |
糖ガラス化ウィルス様粒子（ｖｌｐ）
|
|
US8404850B2
(en)
|
2008-03-13 |
2013-03-26 |
Southwest Research Institute |
Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
|
|
US8722706B2
(en)
|
2008-08-15 |
2014-05-13 |
Southwest Research Institute |
Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
|
|
US8309134B2
(en)
|
2008-10-03 |
2012-11-13 |
Southwest Research Institute |
Modified calcium phosphate nanoparticle formation
|
|
WO2011007327A2
(en)
*
|
2009-07-16 |
2011-01-20 |
Koninklijke Philips Electronics N.V. |
Suspension for therapeutic use and device for delivering said suspension
|
|
US8293299B2
(en)
|
2009-09-11 |
2012-10-23 |
Kraft Foods Global Brands Llc |
Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids
|
|
CN102115737B
(zh)
*
|
2009-12-31 |
2015-06-03 |
深圳迈瑞生物医疗电子股份有限公司 |
稳定碱性磷酸酶或其标记物的试剂和方法
|
|
US9028873B2
(en)
|
2010-02-08 |
2015-05-12 |
Southwest Research Institute |
Nanoparticles for drug delivery to the central nervous system
|
|
CN102269762B
(zh)
|
2010-06-04 |
2014-12-10 |
深圳迈瑞生物医疗电子股份有限公司 |
结合物的制备方法及相关试剂盒
|
|
CN102269761A
(zh)
|
2010-06-04 |
2011-12-07 |
深圳迈瑞生物医疗电子股份有限公司 |
一种碱性磷酸酶结合物的合成工艺
|
|
US8512679B2
(en)
|
2011-03-04 |
2013-08-20 |
Elwha Llc |
Glassy compositions
|
|
BR112014005499B1
(pt)
|
2011-09-09 |
2020-09-15 |
Kraft Foods Group Brands Llc |
Concentrado líquido de bebida de café infundido e seu método de preparação
|
|
SG10201604104PA
(en)
|
2011-10-25 |
2016-07-28 |
Prothena Therapeutics Ltd |
Antibody formulations and methods
|
|
US11013248B2
(en)
|
2012-05-25 |
2021-05-25 |
Kraft Foods Group Brands Llc |
Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings
|
|
US10525057B2
(en)
|
2013-09-24 |
2020-01-07 |
Otsuka Pharmaceutical Co., Ltd. |
Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
|
|
EP3164011A1
(en)
|
2014-07-03 |
2017-05-10 |
Kraft Foods Group Brands LLC |
Low water coffee and tea beverage concentrates and methods for making the same
|
|
CN111558046A
(zh)
*
|
2020-05-27 |
2020-08-21 |
华润昂德生物药业有限公司 |
海藻糖在制备重组人促红素液体制剂中的应用及重组人促红素液体制剂、制备方法和应用
|